Reversing effect of dimethyl-4,4'-dimethoxy-5,6,5',6'dimethylenedioxybiphynyl-2,2'-dicarboxylate (DDB) on the phenotypes of human hepatocarcinoma cells line

Cancer Letters

Volumn 108, Issue 1, 1996, Pages 67-72

  Liu, Zhiyi ^a,c   Liu, Gengtao ^a   Zhang, Shifu ^b  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

fetoprotein; Albumin; Dimethyl 4,4' dimethoxy 5,6,5',6 dimethylenedioxybiphynyl 2,2' dicarboxylate (DDB); Human hepatocarcinoma line

Indexed keywords

ALBUMIN; ALPHA FETOPROTEIN; AMINOTRANSFERASE; CYCLIC AMP; DIMETHYL 4,4' DIMETHOXY 5,6,5',6' DIMETHYLENEDIOXYBIPHYNYL 2,2' DICARBOXYLIC ACID; GAMMA GLUTAMYLTRANSFERASE; LIVER PROTECTIVE AGENT; PROTEIN P53; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; ENZYME REGULATION; GENE ACTIVATION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECRETION; TUMOR SUPPRESSOR GENE;

ALPHA-FETOPROTEINS; BIPHENYL COMPOUNDS; CARCINOMA, HEPATOCELLULAR; CYCLIC AMP; DIOXOLES; GAMMA-GLUTAMYLTRANSFERASE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, P53; HUMANS; LIVER NEOPLASMS; NEOPLASM PROTEINS; PHENOTYPE; SERUM ALBUMIN; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TYROSINE TRANSAMINASE;

EID: 0030581609     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(96)04389-3     Document Type: Article

References (15)

1. [1] Liu, G.T. (1989) Introduction to diphenyl dimethyl dicarboxylate, J. Biomed. Lab. Sci., 2, 230-235.
2. [2] Qing, W.G. and Liu, G.T. (1992) Protective effect of dimemyl-4,4′-dimethoxy-5,6,5′,6′-dimethylene dioxybiphenyl-2,2′-dicarboxylate (DDB) against carcinogen-induced rat liver nuclear DNA damage, Biomed. Environ. Sci., 5, 201-208.
3. [3] Liu, G.T. and Lesca, P. (1982) Pharmacological Properties of dibezo cyclooctene derivatives isolated from fructus schizandrae chinensis I, Chem. Biol. Interact., 41, 39-48.
4. [4] Yu, H.Q., Yang, X.Y., Zhang, Y.X. and Shi, J.Z. (1987) Biphenyl dimethyl dicarboxylate in treating and preventing hepatitis due to drug poisoning, Chin. Med. J., 100, 122-123.
5. [5] Yan, R.Q., Chen, Z.Y. and Qin, G.Z. (1986) Effect of bifendati and three Chinese traditional medicinal herbs on the AFB 1-induced heptocarcinogenesis in rats, Chin. J. Cancer, 2, 141-145.
6. [6] Chen, R.M., Zhu, D.H. and Yie, X.Z. (1978) Establishment and fixtures of human hepatocarcinoma cell line, Bel-7402, Acta Biol. Exp. Sin., 11, 37-42.
7. [7] Khillan, J.S., Oskarsson, M.K., Propst, F., Kuwabara, T., Vando Woude, G.F. and Westphal, H. (1987) Defects in lens fiber differentiation are linked to c-mos overexpression in transgenic mice, Genes Dev., 1, 1327-1335.
8. [8] Bishop, J.M. (1991) Molecular themes in oncogenesis, Cell, 64, 235-248.
9. [9] Huseby, N.E. and Stromme, J.H. (1974) Practical points regarding routine determination of γ-GT in serum with a kinetic method at 37°C, Scand. J. Clin. Lab. Invest., 34, 357-363.
10. [10] Diamondstone, T.L. (1966) Assay of tyrosine transaminase activity by conversion of p-hydroxyphenylpyruvate to p-hydroxybenzaldehyde, Anal. Biochem., 16, 342-395.
11. [11] Lowry, O.K., Rosebrough, N.L. and Randall, R.J. (1951) Protein measurement with the Folin phenol reagent, J. Biol. Chem., 193, 265-275.
12. [12] Chirgwin, J.M., Przybyla, A.B., Macdonald, R.J. and Rutter, W.J. (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease, Biochemistry, 18, 5294-5299.
13. [13] Huang, D.P., Cote, G.J., Massari, R.J. and Chiu, J.F. (1985) Dexamethasone inhibits α-fetoprotein gene transcription in neonatal rat liver and isolated nuclei. Nucleic Acids Res., 13, 3873-3890.
14. [14] Liu, W.H. and Xue, S.P. (1987) Steady expression on induced differentiation of HL-60-AR leukemia cell line, Acta Biol. Exp. Sin., 20, 459-467.
15. [15] Liu, Z.Y., Cui, Q. and Liu, G.T. (1996) Effect of dimethyl-4,4′-dimethoxy-5,6,5′,6′dimethylenedioxybiphenyl-2,2′-dicarboxylate (DDB) on several phenotypes of Bel-7402 hepatocarcinoma cell line and its mechanism. Acta Pharm. Sin., 31, 101-106